GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Related products :

Catalog number Product name Quantity
2130-99-6 N-Cbz-L-Isoleucine-p-nitrophenyl ester N-Cbz-L-Isoleucine-p-ni 1g
10512-93-3 Z-L-Valine 4-nitrophenyl ester Z-L-Valine 4-nitropheny 1g
MEL12-500ML Cell Culture Media,Minimum Essentials Medium,EMEM,With Earle's salts, L-glutamine, and 92 mg_L D-valine substituted for L-valine. 500ml
orb62031 D-Valine D-Valine For research use only. 400 g
37869-33-3 N-Dodecanoyl-valine mono sodium salt N-dodecanoyl- Valine 1g
58185-39-0 N-Tetradecanoyl-Valine mono sodium sa N-tetradecanoyl- Valine 1g
93839-03-3 N-acetyl-L-valine, compound with 2-(dim N-acetyl-L-valine, comp 1g
30-956 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
30-957 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
158257-41-1 Valine NCA Valine NCA 1g
3588-63-4 n-Cbz-dl -valine n-Cbz-dl -valine 1g
27-171 ERLIN2 plays an important role in the early steps of the endoplasmic reticulum-associated degradation (ERAD) pathway. It is involved in ITPR1 degradation by the ERAD pathway. 0.05 mg
31-050 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. It inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 w 0.05 mg
19461-38-2 N-Glycyl-L-isoleucine n-glycyl-l-isoleucine 1g
29588-88-3 Phthaloyl-L-isoleucine Phthaloyl-L-isoleucine 1g
4125-98-8 N-a-Methyl-L-isoleucine N-a-Methyl-L-isoleucine 1g
3077-46-1 N-Acetyl-L-Isoleucine N-Acetyl-L-Isoleucine 1g
6001-78-8 4_Hydroxy Isoleucine 4_Hydroxy Isoleucine 1g
31-051 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 whil 0.1 mg
14379-28-3 N-dodecanoyl-Valine N-dodecanoyl-Valine 1g
17916-88-0 N-Acetyl-d-valine N-Acetyl-d-valine 1g
3067-19-4 N-Acetyl-DL-valine N-Acetyl-DL-valine 1g
4289-97-8 N-Formyl-L-valine N-Formyl-L-valine 1g
14379-30-7 N-Tetradecanoyl-Valine N-tetradecanoyl- Valine 1g
88930-14-7 N-Methyl-D-valine N-Methyl-D-valine 1g

Pathways :

WP1451: Valine, leucine and isoleucine degradation
WP1717: Valine, leucine and isoleucine degradation
WP1716: Valine, leucine and isoleucine biosynthesis
WP198: Isoleucine, Leucine, and Valine biosynthesis
WP178: Isoleucine Degradation
WP354: Leucine Degradation
WP359: Isoleucine and Valine biosynthesis
WP101: Synthesis and Degradation of Ketone Bodies
WP1015: Synthesis and Degradation of Ketone Bodies
WP1079: Proteasome Degradation
WP1134: Synthesis and Degradation of Ketone Bodies
WP1196: Proteasome Degradation
WP1240: Proteasome Degradation
WP158: Proteasome Degradation
WP1612: 1,2-Dichloroethane degradation
WP1613: 1,4-Dichlorobenzene degradation
WP1614: 1- and 2-Methylnaphthalene degradation
WP1615: 3-Chloroacrylic acid degradation
WP1623: Atrazine degradation
WP1626: Benzoate degradation via CoA ligation
WP1627: Benzoate degradation via hydroxylation
WP1632: Biphenyl degradation
WP1633: Bisphenol A degradation
WP1636: Caprolactam degradation
WP1637: Carbazole degradation

Related Genes :
[BCAT3 At3g49680 T16K5.30] Branched-chain-amino-acid aminotransferase 3, chloroplastic (Atbcat-3) (EC 2.6.1.42) (EC 2.6.1.88)
[BCAT1] Branched-chain amino acid aminotransferase 1, mitochondrial (HlBCAT1) (EC 2.6.1.42)
[BCAT2] Branched-chain amino acid aminotransferase 2, chloroplastic (HlBCAT2) (EC 2.6.1.42)
[BAT2 TWT2 YJR148W J2209] Branched-chain-amino-acid aminotransferase, cytosolic (BCAT) (EC 2.6.1.42) (Protein TWT2)
[BAT1 ECA39 TWT1 YHR208W] Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT) (EC 2.6.1.42) (Protein ECA39) (Protein TWT1)
[ilvE b3770 JW5606] Branched-chain-amino-acid aminotransferase (BCAT) (EC 2.6.1.42) (Transaminase B)
[ilvK ywaA BSU38550 ipa-0r] Branched-chain-amino-acid aminotransferase 2 (BCAT 2) (EC 2.6.1.42) (Vegetative protein 85) (VEG85)
[Bcat2 Bcatm Eca40] Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42)
[ilvE MSMEG_4276 MSMEI_4176] Branched-chain-amino-acid aminotransferase (BCAT) (EC 2.6.1.42)
[ilvE Rv2210c MTCY190.21c] Branched-chain-amino-acid aminotransferase (BCAT) (EC 2.6.1.42)
[BCAT2 BCATM BCT2 ECA40] Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42) (Placental protein 18) (PP18)
[BCAT1 BCT1 ECA39] Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)
[ilvE ybgE BSU02390] Branched-chain-amino-acid transaminase 1 (BCAT 1) (EC 2.6.1.42)
[eca39 SPBC428.02c SPBC582.12c] Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT) (EC 2.6.1.42)
[Bcat2 Bcatm Eca40] Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42)
[BCAT2 At1g10070 T27I1.9] Branched-chain-amino-acid aminotransferase 2, chloroplastic (Atbcat-2) (EC 2.6.1.42)
[ilvE STM3903 STMD1.89] Branched-chain-amino-acid aminotransferase (BCAT) (EC 2.6.1.42) (Transaminase B)
[BCAT6 At1g50110 F2J10.4] Branched-chain-amino-acid aminotransferase 6 (Atbcat-6) (EC 2.6.1.42)
[Bcat1 Eca39] Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)
[Bcat1] Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42)
[braC PA1074] Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein (LIVAT-BP) (Leu/Ile/Val/Thr/Ala-binding protein)
[BCAT1 At1g10060 T27I1.8] Branched-chain-amino-acid aminotransferase 1, mitochondrial (Atbcat-1) (EC 2.6.1.42)
[ileS ilvS b0026 JW0024] Isoleucine--tRNA ligase (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)
[ldh] Leucine dehydrogenase (LeuDH) (EC 1.4.1.9)
[BCAT5 At5g65780 F6H11.110 MPA24.13] Branched-chain-amino-acid aminotransferase 5, chloroplastic (Atbcat-5) (EC 2.6.1.42)
[bcat-1 eca-39 eca39 K02A4.1] Branched-chain-amino-acid aminotransferase, cytosolic (BCAT) (EC 2.6.1.42) (ECA39 protein)
[VAT1 At5g16290 MQK4.1] Acetolactate synthase small subunit 1, chloroplastic (Acetohydroxy-acid synthase small subunit) (AHAS) (ALS) (Protein valine-tolerant 1)
[vdh SCO4089 SCD25.25c] Valine dehydrogenase (ValDH) (EC 1.4.1.23)
[ileS TTHA1067] Isoleucine--tRNA ligase (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)
[valS] Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)

Bibliography :
[30879189] The association of sleep with metabolic pathways and metabolites: evidence from the Dietary Approaches to Stop Hypertension (DASH)-sodium feeding study.
[30832316] Characterization of Yak Common Biofluids Metabolome by Means of Proton Nuclear Magnetic Resonance Spectroscopy.
[30830480] Metabolomic analyses reveal lipid abnormalities and hepatic dysfunction in non-human primate model for Yersinia pestis.
[30830240] Enhanced cerebral branched-chain amino acid metabolism in R6/2 mouse model of Huntington's disease.
[30827756] Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
[30821190] Effects of leucine supplementation on muscle protein synthesis and degradation pathways in broilers at constant dietary concentrations of isoleucine and valine.
[30805535] The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients.
[30802212] Metabolomic study of altered energy metabolism during global forebrain ischemia and ischemic precoditioning in blood plasma in homocysteine treated rats.
[30793530] The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
[30784822] Integrated application of transcriptomics and metabolomics provides insights into unsynchronized growth in pearl oyster Pinctada fucata martensii.